Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy.

@article{Asbell1996DevelopmentOA,
  title={Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy.},
  author={Sucha O. Asbell and Susan A Leon and William J. Tester and Harmar D Brereton and Casely Ago and Marvin H Rotman},
  journal={The Prostate},
  year={1996},
  volume={29 4},
  pages={243-8}
}
BACKGROUND The objective of this study was to document previously unreported anemia in prostate cancer patients treated with neoadjuvant combined androgen blockade (CAB) and pelvic radiotherapy (XRT). METHODS Four institutions treated 141 patients (mean age +/- SD, 70.9 +/- 6.5 years) with zoladex 3.6 mg injection subcutaneous depot monthly and flutamide 250 mg orally three times per day for 2 months (CAB), followed by zoladex and flutamide with concurrent XRT (65-70 Gy) for 7-8 weeks… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…